Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page has been updated to reflect the submission of results and has been revised to version 2.15.2.SummaryDifference0.8%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check34 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 30, 2025, while a date for March 25, 2025, has been removed.SummaryDifference1.0%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check92 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check99 days agoChange DetectedThe website has been updated to version v2.14.2, with the previous status of 'Active, not recruiting' removed.SummaryDifference1%
Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.